English Italiano

Cooperating groups

Gruppo Italiano per la Sopravvivenza nell’Infarto Miocardio - GISSI

GISSI is a product of the collaboration between the Mario Negri Institute and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO). Today it is considered one of the best-qualified research  teams in the cardiovascular field. GISSI has produced a series of large-scale clinical trials (GISSI 1, GISSI 2, GISSI 3, GISSI Prevenzione), involving over 60,000 patients with myocardial infarction.
In the twenty years since GISSI was set up, its studies have been widely recognized by the international cardiology community and are considered a methodological landmark.
GISSI’s work has now spread from myocardial infarction to other cardiovascular pathologies with a wide impact, like heart failure and atrial fibrillation, on which large-scale clinical studies are now in progress.
For more information, please se the GISSI website.

Italian Group for the Evaluation of Interventions in Intensive Care Medicine - GiViTI

GiViTI was founded in 1991. It’s research projects are aimed at the continuous evaluation in intensive care units (ICUs) in order to improve the quality of health care and clinical research. The GiViTI network has over 330 participants in Italy.
For more information please see the GIVITI website.


The Risk and Prevention Group

The Risk and Prevention Group
stems from the collaboration between the Mario Negri Institute  and the main associations of Italian General Practitioners : 
Centro Studi e Ricerca in Medicina Generale (CSERMeG); 
Federazione Italiana Medici di Medicina Generale (FIMMG); 
Consorzio Sanità (CoS); 
Associazione Culturale Medica Interdisciplinare (Ass.Cu.M.I.); 
Associazione per la Medicina Integrativa e la Sanità Integrata (AMISI).
The collaborative group is the sponsor of the multicentric “Risk and Prevention” study, at national level. 
This study is the first large community trial which is made possible after implementation of  legislation (DM) regulating clinical research in general practice in Italy.
The study is still ongoing , it will last 5 years , involving approximately 1,000 general practictioners and 12,000 patients. 
The aim of the study is important for Public Health : to optimise preventive strategies in subjects at high cardiovascular risk in the setting of general practice.
More information on Risk & Prevention at :  www.rischioeprevenzione.org